Right atrial dilatation increases inositol-(1,4,5)trisphosphate accumulation Implications for the control of atrial natriuretic peptide release  by von Harsdorf, R. et al.
Volume 233, number l, 201-205 FEB 05935 June 1988 
Right atrial dilatation increases inositol-(1,4,5)trisphosphate 
accumulation 
Implications for the control of atrial natriuretic peptide release 
R. von Harsdorf, R. Lang, M. Fullerton*, A.I. Smith* and E.A. Woodcock* 
German Institute for High Blood Pressure Research, Im Neuenheimer Feld 366, D-6900 Heidelberg, FRG and *Medical 
Research Centre, Prince Henry's Hospital, Melbourne 3004, Australia 
Received 1 March 1988 
Stretching the right atrium of isolated perfused [3H]inositol-labeUed rathearts was shown to stimulate the phosphatidyl- 
inositol turnover pathway as demonstrated by the accumulation of [3H]inositol-(1,4,5)trisphosphate and its degradation 
products. Stimulation was detectable after 1 min with larger increases observed after 10 or 20 min. These findings demon- 
strate that the myocardium can respond to dilatation by an activation of the phosphatidylinositol turnover pathway. 
Such a mechanism has implications for the release of atrial natriuretic peptide following right atrial distention. 
Atrial stretch; Inositol phosphate; Inositol-(1,4,5)trisphosphate; Atrialnatriuretic peptide; (Rat heart) 
1. INTRODUCTION 
As it is currently understood the phospha- 
tidylinositol (PtIns) turnover pathway involves the 
hydrolysis of a plasma membrane phospholipid, 
phosphatidylinositol-(4,5)bisphosphate following 
binding of a hormone or neurotransmitter to an 
appropriate receptor. This hydrolysis yields two 
second messengers, n-l,2-diacylglycerol (DAG) 
and inositol-(1,4,5)trisphosphate (Ins(1,4,5)P3). 
DAG stimulates the membrane-bound phospho- 
lipid-dependent, Ca2+-dependent protein kinase C 
and Ins(1,4,5)P3 releases calcium from endo- 
plasmic reticulum stores in a number of different 
tissues [1]. The PtIns turnover pathway has been 
well studied in many tissues but relatively little 
detailed information is available for myocardial 
tissue. In isolated ventricular myocytes [2], ven- 
tricle strips [3], perfused ventricles [4] and intact 
perfused hearts [5], 2-4-fold stimulations by 
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noradrenaline (c~t-receptors) and acetylcholine 
(muscarinic receptors) have been observed. In the 
present study isolated perfused rat hearts have 
been used to study the PtIns turnover esponse to 
right atrial distention, a stimulus known to cause 
release of atrial natriuretic peptide. 
2. MATERIALS AND METHODS 
2.1. Preparation of [~H]inositol-labelled hearts 
The methods used for the preparation of [3H]inositol-labeUed 
perfused hearts were essentially as described previously [5,6]. 
The rats used in the current study weighed 30(0350 g and 
phospholipids were labelled by perfusing for 2 h with [3H]ino- 
sitol (Amersham, Bucks, England) (10/~Ci/ml). Following the 
labelling period, the perfusion was continued for 10 min with 
5 x 10 -3 M non-radioactive inositol and 10 -2 M LiCI. In hearts 
to be subjected to right atrial stretch, a latex balloon (size 5, ob- 
tained from Hugo Sacks, Elektronic 7801 Masch-Hugotetten, 
FRG) was inserted into the right atrium via the inferior vena 
cava prior to the labelling. The balloon was attached to a 1 ml 
syringe via a catheter and inflated to a volume of 75/zl. The 
stretch signal was terminated by chilling the hearts in ice-cold 
saline. Right atria were dissected, weighed and inositol 
phosphates xtracted using a chloroform/methanol extraction 
method as described elsewhere [7]. 
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2.2. Separation and identification of inositol phosphates 
Water-soluble [3H]inositol-labelled compounds were 
separated using anion-exchange high-performance liquid 
chromatography as described elsewhere [6] or Dowex column 
chromatography [7]. The column used was a Whatman partisil 
SAX column packed by Waters (Milford, MA, USA) for use in 
a radial compression system on a Waters model 441 liquid 
chromatograph. [3H]Inositol-labelled compounds were eluted 
using a linear gradient of 0-2  M ammonium formate buffered 
to pH 3.7 with phosphoric acid. The flow rate was 1 ml/min. 
lns-lP, Ins(l,4)P2 and Ins(1,4,5)P3 were identified using 3H- 
labelled standards (from Amersham, Bucks, England). 3p. 
labelled glycerophosphoinositol, glycerophosphoinositol- 
4-phosphate and glycerophosphoinositol-(4,5)bisphosphate 
were prepared as described by Downes et al. [8]. Standard 
Ins(l,3,4,5)P4 was prepared from [3H]Ins(l,4,5)P3 using a 
crude preparation of Ins(1,4,5)P3 kinase from rat brain [6,9]. 
2.3. Assay of atrial natriuretic peptide (ANP) 
ANP was measured using a radioimmunoassay as described 
elsewhere [10]. 
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Fig.l. Effect of 10 min right atrial dilatation on the profile of inositol phosphates in right atria. HPLC analysis was performed as 
explained in section 2. GPI, glycerophosphoinositol; GPIP, glycerophosphoinositol-4-phosphate; GPIP2, glycerophosphoino- 
sitol-(4,5)bisphosphate. Th  experiment was performed 4 times with similar results. 
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3. RESULTS 
3.1. Effect of 10 min right atrial dilatation on 
inositol phosphate accumulation 
[3H]Inositol-labelled rathearts were subjected to 
10 min dilatation of the right atrium. Water- 
soluble, [3H]inositol-labelled products were ex- 
tracted and examined using anion-exchange high- 
performance liquid chromatography. An increase 
in Ins(1,4,5)P3 was observed in right atria follow- 
ing 10 min dilatation, together with increases in its 
degradation products, Ins(1,4)P2 and Ins-lP 
(fig.l). In four different experiments he average 
cpm in Ins(1,4,5)P3 in dilated atria was 7850 _+ 
1700 (cpm/g tissue; mean + SE) compared with 
4523 _+ 1200 in control preparations (P 
< 0.01, Perutz F-test). Other peaks on the 
chromatograms were identified as glycerophos- 
phoinositol (GPI), glycerophosphoinositol-4- 
phosphate (GPIP) and glycerophosphoinositol- 
(4,5)bisphosphate (GPIP2). These compounds 
were not increased by right atrial stretch. Profiles 
obtained in right atria were similar to those re- 
ported previously in ventricular tissue and differed 
from those reported in other tissues [6]. In none of 
the profiles observed in atria was there any peak at 
the position of Ins(1,3,4,5)P4 or any of its dephos- 
phorylation products. Similar profiles have been 
reported by others in muscle cells in culture [11]. 
Thus atria, like ventricles, appear to lack the prod- 
ucts of the Ins(1,4,5)P3 kinase pathway, at least 
under the conditions of our perfused heart prepa- 
rations. However, others have reported finding 
Ins(1,4,5)P3 kinase activity in rat heart prepara- 
tions [4]. 
3.2. Time dependence of Ptlns responses to right 
atrial dilatation 
Effects of right atrial dilatation on inositol 
phosphate accumulation i the right atrium itself 
were detectable after 1 min balloon stretching, 
with larger increases being observed after 10 or 
20 min (fig.2). Increases in InsP1, InsP2 and InsP3 
were observed. These experiments were performed 
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Fig.2. Accumulation of inositol phosphates in the right atria of 
isolated, perfused rat hearts subjected to right atrial dilatation 
for l, 10 and 20 min. Values shown are mean _+ SE of 6-8 
experiments (** P < 0.01 and * P < 0.05, Perutz F-test [19]). 
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Fig.3. Effect of right atrial dilatation on the release of atrial 
natriuretic peptide (ANP) into the perfusate. Dilatation was 
performed as described in the legend to fig. 1. Values shown are 
mean _+ SE of 4 hearts from the 20 min dilated group shown in 
fig.2. (e) Control; (x) right atrial dilatation. 
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using Dowex column chromatography to separate 
the inositol phosphates. Preliminary experiments 
had demonstrated that the InsP2 and InsP3 frac- 
tions contained, in addition, glycerophosphoinosi- 
tol-4-phosphate and glycerophosphoinositol- 
(4,5)bisphosphate, r spectively. As these products 
did not change during dilatation, results obtained 
using column chromatography should underes- 
timate changes in inositol phosphates. Addition of 
1/~M concentrations of propranolol, prazosin and 
atropine to block respectively ~'-adrenoceptors, 
~l-adrenoceptors and muscarinic acetylcholine 
receptors did not alter the response indicating that 
it was not secondary to release of noradrenaline or 
acetylcholine. 
3.3. Release of ANP 
Dilatation of the right atrium also caused an in- 
crease in the release of ANP into the perfusate. 
ANP release from hearts with right atriaily dilated 
for 20 min is shown in fig.3. Release of ANP con- 
tinued steadily for 12 min and plateaued 
thereafter. 
4. DISCUSSION 
Experiments in vivo and in vitro have 
demonstrated release of ANP following distention 
of the right atrium but the mechanism whereby 
such a stimulus is transmitted has remained 
unknown. Atrial stretch has been reported to in- 
crease calcium influx by causing plasma membrane 
depolarization [12] and the increased cytosolic 
calcium might stimulate release of ANP. Other 
studies have shown that noradrenaline acting at 
at-adrenoceptors can stimulate release of ANP, 
apparently by activation of the Ptlns turnover 
pathway [13]. Direct stimulation of this pathway 
using phorbol esters and calcium ionophores also 
releases ANP from atria in vitro [14]. Thus, to 
date, the best described stimulants of ANP release 
are atrial stretch or activation of the Ptlns 
turnover pathway. In this study we have addressed 
the question of a possible relationship between 
atrial stretch and activation of the Ptlns turnover 
pathway and have shown that stretching the right 
atrium causes an activation of this pathway. 
Stimulation was not secondary to release of 
neurotransmitters. Furthermore, Ptlns turnover in 
heart is not stimulated by increases in cytosolic 
calcium [2,5], making it unlikely that the response 
to dilatation ismediated by calcium. While media- 
tion by some other change caused by dilatation 
cannot be ruled out, it remains possible that 
'stretch receptors' can directly activate the Ptlns- 
(4,5)P2-specific phospholipase C.
Ins(l,4,5)P2 has been reported to be active [15], 
inactive [16] and weak [17] in releasing calcium 
from cardiac sarcoplasmic reticulum. Therefore its 
role in the heart is unclear. The other second 
messenger released in concert with Ins(1,4,5)P3, 
DAG, via its activation of protein kinase C, can 
activate calcium channels in the sarcolemma [18]. 
Such a mechanism ay be important in raising in- 
tracellular calcium concentrations which in turn 
may be important in stimulating release of ANP 
and in increasing myocardial contractility. Clearly, 
the data do not prove that ANP release following 
right atrial dilatation is mediated by the Ptlns 
turnover pathway. However, stimulation of Ptlns 
turnover, either by receptor activation or by phor- 
bol esters and calcium ionophores can release 
ANP. Therefore, it is reasonable to suggest hat 
stimulation of Ptlns turnover at least contributes 
to the stimulated release of ANP following dilata- 
tion of the right atrium. 
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